HSBC HOLDINGS PLC - PROTAGONIST THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,173,748
-41.4%
554,305
-1.1%
0.01%
-37.5%
Q2 2023$15,653,508560,4550.02%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$20,647,0006.08%
Bain Capital Life Sciences Investors, LLC 2,260,572$19,057,0002.28%
Kynam Capital Management, LP 519,212$4,377,0000.92%
RTW INVESTMENTS, LP 4,176,837$35,211,0000.81%
Tri Locum Partners LP 199,500$1,682,0000.46%
Birchview Capital, LP 38,000$320,0000.22%
Gratus Capital, LLC 206,113$1,738,0000.18%
FARALLON CAPITAL MANAGEMENT LLC 3,651,887$30,785,0000.17%
PDT Partners, LLC 126,038$1,063,0000.16%
FOX RUN MANAGEMENT, L.L.C. 40,683$343,0000.13%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders